Notably, increasing evidence suggests that IL-27 can modulate MS and experimental autoimmune encephalomyelitis (EAE) course [18–20], but whether astrocytes contribute to such effects is still unclear. The gene discussed is IL27; the disease is myeloid sarcoma.